OS Therapies (OSTX) Stock Price, News & Analysis

Company Overview

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Rockville, Maryland.

Key Stats

• Today's Range: $3.63 to $4.46
• 50-Day Range: $1.74 to $4.71
• 52-Week Range: $1.58 to $6.48
• Volume: 93,044 shs
• Average Volume: 129,147 shs
• Market Capitalization: $81.34 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $8.00
• Consensus Rating: Strong Buy

OSTX Stock Analysis - Frequently Asked Questions

How have OSTX shares performed this year?

OS Therapies' stock was trading at $4.00 at the start of the year. Since then, OSTX stock has decreased by 4.3% and is now trading at $3.83.
View the best growth stocks for 2024 here.

When did OS Therapies IPO?

OS Therapies (OSTX) raised $8 million in an initial public offering on Thursday, August 1st 2024. The company issued 2,000,000 shares at a price of $4.00 per share. Brookline Capital Markets (Division of Arcadia Securities LLC) acted as the underwriter for the IPO.

When does OS Therapies' lock-up period expire?

OS Therapies' lock-up period expires on Tuesday, January 28th. OS Therapies had issued 1,600,000 shares in its IPO on August 1st. The total size of the offering was $6,400,000 based on an initial share price of $4.00. After the expiration of OS Therapies' lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted.

Who are OS Therapies' major shareholders?

OS Therapies' top institutional investors include Virtu Financial LLC (0.05%).

How do I buy shares of OS Therapies?

Shares of OSTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of OS Therapies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that OS Therapies investors own include AST SpaceMobile (ASTS), Energy Transfer (ET), Black Stone Minerals (BSM), Kinder Morgan (KMI), Main Street Capital (MAIN), Atlas Energy Solutions (AESI) and Chevron (CVX).

Company Calendar

• Today: 12/25/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NYSE:OSTX
• Previous Symbol: NYSE:OSTX
• CUSIP: N/A
• CIK: 1795091
• Web: N/A
• Phone: (410) 297-7793
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $8.00
• High Stock Price Target: $8.00
• Low Stock Price Target: $8.00
• Potential Upside/Downside: +108.9%
• Consensus Rating: Strong Buy
• Rating Score (0-4): 3.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-7,790,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -569.57%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.76
• Quick Ratio: 0.76

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 21,238,000
• Free Float: N/A
• Market Cap: $81.34 million
• Optionable: N/A
• Beta: N/A